|
|||||
|
|
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression |
|
| Authors: | Harneek Chohan MSc Konstantin Senkevich MD PhD Radhika K Patel Jonathan P Bestwick MSc Benjamin M Jacobs BM BCh Sara Bandres Ciga PhD Ziv Gan-Or MD PhD Alastair J Noyce MRCP PhD |
| Institution: | 1. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK;2. Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada
Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada H.C. and K.S. contributed equally to this work.;3. Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA;4. Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada Department of Human Genetics, McGill University, Montréal, Quebec, Canada |
| Abstract: | |
| Keywords: | Parkinson's disease type 2 diabetes |